Medical company Intuitive Surgical (ISRG.US), which is responsible for, among other things, the production of the innovative da Vinci surgical robots, is gaining nearly 9% on the stock market today, after the company's financial results for the third quarter of this year came in well above market expectations.
Highlights from the Q3 report:
Start investing today or test a free demo
Create account Try a demo Download mobile app Download mobile app- Adjusted earnings per share: $1.84 (estimate $1.64); +26% y/y
- Revenues: $2.04 billion (estimate $2 billion); +17% y/y
- Revenue from instruments and accessories: $1.26 billion (estimate $1.24 billion); +18% y/y
- Systems revenue: $445 million (vs. $379 million y/y); +17% y/y
Operating indicators:
- da Vinci procedures worldwide: +15% y/y
- Installed base of da Vinci surgical systems: 9539 systems (vs. 8285 y/y); +15%
- New da Vinci system deployments: 379 (vs. 312 y/y)
- da Vinci 5 systems: 110 units
- Operating leases: 220 systems, including 141 under usage-based leases
Business updates:
- Regulatory approval: received approval in South Korea for da Vinci 5 surgical system for multiple procedures (urology, thoracic, gynecological, etc.).
Cash and capital structure:
- Cash, cash equivalents and investments: $8.31 billion (up $628 million quarter-on-quarter)
The company's shares rocketed to new highs after the release of strong quarterly results. Source: xStation
This content has been created by XTB S.A. This service is provided by XTB S.A., with its registered office in Warsaw, at Prosta 67, 00-838 Warsaw, Poland, entered in the register of entrepreneurs of the National Court Register (Krajowy Rejestr Sądowy) conducted by District Court for the Capital City of Warsaw, XII Commercial Division of the National Court Register under KRS number 0000217580, REGON number 015803782 and Tax Identification Number (NIP) 527-24-43-955, with the fully paid up share capital in the amount of PLN 5.869.181,75. XTB S.A. conducts brokerage activities on the basis of the license granted by Polish Securities and Exchange Commission on 8th November 2005 No. DDM-M-4021-57-1/2005 and is supervised by Polish Supervision Authority.
